| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 03/18/2008 | US7345068 Aromatic amino acid derivatives and medicinal compositions |
| 03/18/2008 | US7345055 2,7-dimethylimidazo[1,2- alpha ]pyridin-3-ylmethyl)-dimethylamine; nitric oxide synthase inhibitor; neurodegenerative diseases and antiinflammatory, antitumor agent; multiple sclerosis, Parkinson's, Alzheimer's or Huntington's disease, cerebral ischemia, diabetes, meningitis, angiogenesis, |
| 03/18/2008 | US7345054 Heterocyclic inhibitors of ERK2 and uses thereof |
| 03/18/2008 | US7345050 Imidazo(1,2a)pyridine or pyrazolo(2,3a)pyridine derivatives; Alzheimer's and Parkinson's Disease; nervous system, brain, and psychological disorders |
| 03/18/2008 | US7345049 Phenylalanine derivatives |
| 03/18/2008 | US7345048 Heterocyclic compounds and uses thereof as D-alanyl-D-alanine ligase inhibitors |
| 03/18/2008 | US7345045 Pyrido-pyrimidine compounds as medicaments |
| 03/18/2008 | US7345040 Piperimido[1,2-a]piperazine-4,7diones derivatives; neurokinin (tachykinin) receptor antagonists; mimic the secondary structure of reverse-turn regions of biologically active peptides and proteins; analgesic, neurodegenerative disorders, respiratory diseases, antiinflammatory agent, antidepressant |
| 03/18/2008 | US7345038 Pyridyloxymethyl and benzisoxazole azabicyclic derivatives |
| 03/18/2008 | US7345037 ipratropium/flutropium/tiotropium derivatives; anticholinergic agent; linked at NO or NO2 group, or group which stimulates endogenous production of NO; beneficial therapeutic effects; asthma, respiratory disorder, cystic fibrosis; synergistic with NO release agent or substrate for nitric oxide synthase |
| 03/18/2008 | CA2394120C Tricyclic fused heterocyclic compound, process for preparing it and medicament comprising it |
| 03/13/2008 | WO2008030511A2 Substituted 3,4,6,7-tetrahydro-5h, 1,2a,4a,8-tetraazacyclopenta[cd]phenalenes |
| 03/13/2008 | WO2008030466A1 Phthalazine, aza- and diaza-phthalazine compounds and methods of use |
| 03/13/2008 | WO2008029907A1 Hypertension-ameliorating agent |
| 03/13/2008 | WO2008029882A1 2-alkyl-6-(pyrazolopyridin-4-yl)pyridazinone derivative, addition salt thereof, and pde inhibitor comprising the derivative or the salt as active ingredient |
| 03/13/2008 | WO2008029829A1 Pyrazolopyridine derivative and phosphodiesterase (pde) inhibitor containing the same as active ingredient |
| 03/13/2008 | WO2008028959A1 Crystalline form of moxifloxacin hydrochloride |
| 03/13/2008 | WO2008028617A1 Heteroaryl derivatives as protein kinase inhibitors |
| 03/13/2008 | WO2007148185A3 Substituted 3 -amino- pyrrolidino-4 -lactams as dpp inhibitors |
| 03/13/2008 | WO2007146376A3 Substituted 3-cyanopyridines as protein kinase inhibitors |
| 03/13/2008 | WO2007136570A3 5,6-fused pyrrolidine compounds useful as tachykinin receptor antagonists |
| 03/13/2008 | WO2007127635A3 Diketo-piperazine and piperidine derivatives as antiviral agents |
| 03/13/2008 | US20080064734 Mixture with other active materials; controlling glucose metabolism; diabetes |
| 03/13/2008 | US20080064719 Crf Receptor Antagonists And Methods Relating Thereto |
| 03/13/2008 | US20080064717 Type 2 diabetes, obesity, elevated plasma triglycerides, metabolic syndrome, non-alcoholic steatohepatitis, and non-alcoholic fatty liver disease; N-(3-chlorophenyl)-N'-(4'-{(R)-hydroxy[(1R,2R)-2-(hydroxymethyl)cyclopentyl]methyl}-1,1'-biphenyl-4-yl)urea |
| 03/13/2008 | US20080064716 Biphenyl Integrin Antagonists |
| 03/13/2008 | US20080064715 I kappa B kinase inhibition; diabetes; (7-Chloro-1H-pyrrolo[2,3-c]pyridin-2-yl)methanol; N-Benzyl-7-chloro-1H-pyrrolo[2,3-c]pyridine-2-carboxamide |
| 03/13/2008 | US20080064707 Substituted arylpyrazolopyridines and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same |
| 03/13/2008 | US20080064706 Piperidine Derivatives as Histamine H3 Receptor Ligands |
| 03/13/2008 | US20080060775 8-Oxyl-7,7,9,9-tetramethyl-1,3,8-triaza-spiro[4.5]decane-2,4-dione; antiyellowing agents for lignin |
| 03/13/2008 | CA2662776A1 Spiropiperidine beta-secretase inhibitors for the treatment of alzheimer's disease |
| 03/13/2008 | CA2662705A1 Hypertension-ameliorating agent |
| 03/13/2008 | CA2662031A1 Heteroaryl derivatives as protein kinase inhibitors |
| 03/13/2008 | CA2661992A1 Pyrazolopyridine derivative and phosphodiesterase (pde) inhibitor containing the same as active ingredient |
| 03/12/2008 | EP1897881A2 Compounds useful for the treatment of obesity, type II diabetes and CNS disorders |
| 03/12/2008 | EP1897876A2 Compounds useful for the treatment of obesity, type II diabetes and CNS disorders |
| 03/12/2008 | EP1896481A2 Heterocyclic spiro-compounds as aldosterone synthase inhibitors |
| 03/12/2008 | EP1896473A1 1- ( 2-amino-3- (substituted alkyl)-3h-benzimidazoiylmethyl) -3-subtituted-1,3-dihydro-benzoimidazol-2-ones with activity on respiratory syncytial virus |
| 03/12/2008 | EP1896472A1 Alpha-carbolines as cdk-1 inhibitors |
| 03/12/2008 | EP1896471A1 Imidazopyridine derivatives as acid pump antagonists |
| 03/12/2008 | EP1896470A2 Pyrrolopyridine derivatives as protein kinase inhibitors |
| 03/12/2008 | EP1896428A1 Pyrimidine derivatives for the treatment op gaba b mediated nervous system disorders |
| 03/12/2008 | EP1896422A2 Tyrosine kinase inhibitors |
| 03/12/2008 | EP1896421A2 Benzocycloheptapyridines as inhibitors of the receptor tyrosine kinase met |
| 03/12/2008 | EP1689390A4 Methods and reagents for the treatment of inflammatory disorders |
| 03/12/2008 | EP1641799B1 Imidazo-pyridazinone derivatives and imidazo-pyridone derivatives, production thereof, and use thereof as medicaments |
| 03/12/2008 | EP1560815B1 Novel pyrimidine-4,6-dicarboxamides for the selective inhibition of collagenases |
| 03/12/2008 | CN101142214A Ocaperidone salts and pharmaceutical compositions containing the same |
| 03/12/2008 | CN101142197A N-hydroxyamides omega-substituted with tricyclic groups as histone deacetylase inhibitors, their preparation and use in pharmaceutical formulations |
| 03/12/2008 | CN101142184A Sulfonamide peri-substituted bicyclics for occlusive artery disease |
| 03/12/2008 | CN101139351A Perfluoro alkyl substituted perylene bis diimines and derivative and preparation method thereof |
| 03/12/2008 | CN101139347A Banisterine derivative compound and uses thereof |
| 03/12/2008 | CN101139346A Benzimidazole-derivatives as factor Xa inhibitors |
| 03/12/2008 | CN100374446C Method for separating vindoline , catharanthine, vinblastine and vincristine from Vinca rosea |
| 03/12/2008 | CN100374445C Method for purifying Vinorelbine Bitartrate |
| 03/12/2008 | CN100374440C Spirosubstituted piperidines as selective melanin concentrating hormone receptor antagonists for the treatment of obesity |
| 03/12/2008 | CN100374439C Pyrid (2, 1-a) - isoquinoline derivatives as dpp-iv inhibitors |
| 03/12/2008 | CN100374438C Pre-organized tricyclic integrase inhibitor compounds |
| 03/12/2008 | CN100374437C Blue light-emitting compound for organic electroluminescent apparatus and organic electroluminescent apparatus utilizing the same blue light-emitting compound |
| 03/12/2008 | CN100374114C Antibiotic compositions for treatment of the eye, ear and nose |
| 03/11/2008 | US7342118 Imidazole compounds for the treatment of neurodegenerative disorders |
| 03/11/2008 | US7342115 Binding antagonist and arylpyridine for antiinflammatory agents, cardiovascular disorders and antagonist or agonist and for immunology |
| 03/11/2008 | US7342025 Substituted C-imidazo[1,2-a]pyridin-3-yl-methylamines |
| 03/11/2008 | US7342024 4-Oxo-1-3-substituted phenyl-1,4-dihydro-1,8-naphthyridine-3-carboxamide phosphodiesterase-4 inhibitors |
| 03/11/2008 | US7342014 Diamine derivatives |
| 03/11/2008 | US7342012 Inhibitors of αLβ2 mediated cell adhesion |
| 03/11/2008 | US7341700 Method for recovery of metals from metal-containing materials using medium temperature pressure leaching |
| 03/11/2008 | CA2340230C Pyridazinone derivatives having cell adhesion inhibiting activity |
| 03/06/2008 | WO2008027812A2 Imidazopyridine and imidazopyrimidine derivatives |
| 03/06/2008 | WO2008027182A2 Indoloquinoline compounds as calcium channel blockers |
| 03/06/2008 | WO2008026687A1 Pyrazolopyridine carboxamide derivative and phosphodiesterase (pde) inhibitor comprising the derivative |
| 03/06/2008 | WO2008025947A1 1h-pyrrolo[2,3-b]pyridine derivatives useful as hsp90 inhibitors |
| 03/06/2008 | WO2008025821A1 Triazole derivatives as kinase inhibitors |
| 03/06/2008 | WO2008025512A1 Pyrrolo isoquinolines as kinase inhibitors |
| 03/06/2008 | WO2008006795A3 Indole compounds |
| 03/06/2008 | WO2008003854A3 Derivatives of 2-benzoyl-imidazopyridines, preparation method thereof and use of same in therapeutics |
| 03/06/2008 | WO2007149873A3 Kv1.5 potassium channel inhibitors |
| 03/06/2008 | WO2007100664A3 Modulators of muscarinic receptors |
| 03/06/2008 | WO2007100387A3 Process for preparing tadalafil |
| 03/06/2008 | US20080058519 Quinazoline ditosylate salt compounds |
| 03/06/2008 | US20080058515 indazolylacrylamide derivatives are useful in the treatment of diseases associated with inappropriate SGK-1 activity |
| 03/06/2008 | US20080058502 Method for preparing microparticles having a selected polymer molecular weight |
| 03/06/2008 | US20080058382 Polyamine compounds |
| 03/06/2008 | US20080058369 Pyrazolo[3,4-b]pyridine compounds, and their use as PDE4 inhibitors |
| 03/06/2008 | US20080058368 4,5,6,7-Tetrahydro-[1,2]Dithiolo[4,3-C] Pyridine-3-Thione Compounds |
| 03/06/2008 | US20080058367 Process for the purification of palonosetron or its salt |
| 03/06/2008 | US20080058365 Fused heterocyclic compounds |
| 03/06/2008 | US20080058359 1-[[3-[(1,4,5,6-Tetrahydro-2-pyrimidinyl)amino]phenyl]acetyl]-4-piperidinepropanoic acid; new class of selective modulator of beta 3, beta 5 or dual integrin receptors; anticarcinogenic, antiinflammatory, antidiabetic agent |
| 03/06/2008 | US20080058350 Imidazopyridine and imidazopyrimidine derivatives |
| 03/06/2008 | US20080058348 Bone disorders such as osteoporosis, tumors and cardiovascular disorders; 4-(2-carboxy-2-Boc-aminoethylamino)-6-piperidinopyrimidines such as tert-butyl 2-benzyloxycarbonylamino-3-[2,5-dimethoxy-6-(4-[1,8]naphthyridin-2-yl-piperidin-1-yl)pyrimidin-4-ylamino]-propionate |
| 03/06/2008 | US20080058326 Interfere with Tie2 signalling; Tie (tyrosine kinase with immunoglobulin and epidermal growth factor homology domain) receptor tyrosine kinase; antitumor, antimetastasis agents; for example, 1-[4-(6-tert-Butyl-1H-pyrazolo[3,4-b]pyridin-4-yl)-phenyl]-3-(3-ethyl-phenyl)-urea |
| 03/06/2008 | US20080058319 Fused ring heterocycles as potassium channel modulators |
| 03/06/2008 | US20080058315 Integrase inhibitors |
| 03/06/2008 | US20080054258 to the use of perylene diimide derivatives as air-stable n-type organic semiconductors. for air stable field effect transistors |
| 03/06/2008 | CA2662185A1 Indoloquinoline compounds as calcium channel blockers |
| 03/06/2008 | CA2662074A1 Triazole derivatives as kinase inhibitors |
| 03/06/2008 | CA2661850A1 Pyrazolopyridine carboxamide derivative and phosphodiesterase (pde) inhibitor containing the same |
| 03/06/2008 | CA2661842A1 Serine-threonine protein kinase and parp modulators |
| 03/06/2008 | CA2660980A1 Pyrrolo isoquinolines as kinase inhibitors |
| 03/05/2008 | EP1894932A1 5-amino-2,4,7-trioxo-3,4,7,8-tetrahydro-2H-pyrido[2,3-d]pyrimidine derivatives and related compounds for the treatment of cancer |